← Leaderboards
David E. Clements
Hawaii Biotech, Inc.
$13,267,458
Attributed
$13,267,458
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.4M · FY2011–25$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,267,458 · 9
By mechanism
R44$11,421,927 · 4
R43$1,845,531 · 5
Top collaborators
No co-investigators on record.
Most similar at Hawaii Biotech, Inc.
Same institution · by research overlap
- Beth-Ann Coller$10,591,331
Others in their field
Top investigators on “Vaccine Development”
- Lawrence Corey · Fred Hutchinson Cancer Center$718,120,301
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$554,939,981
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$394,383,754
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$392,263,550
- Dennis R. Burton · Scripps Research Institute$312,611,400
Research focus
Vaccine DevelopmentVirusAdjuvantVaccine CandidateVaccinesInfectionRecombinantsWest Nile VirusHawaiiRecombinant ProteinsNeutralizing AntibodyAntigensAreaDoseInsectaTechnologyCellsDengue VirusBiotechnologySuccessFormulationFamilySafetyImmune Response
Grant awards (22)
Chikungunya Recombinant Subunit Vaccine$998,229
R44 · FY2025 · AI · contact PI
Chikungunya Recombinant Subunit Vaccine$967,053
R44 · FY2024 · AI · contact PI
Development of a Cross-Protective New World Encephalitic Alphavirus Subunit Vaccine$203,325
R43 · FY2024 · AI · contact PI
Development of a Cross-Protective New World Encephalitic Alphavirus Subunit Vaccine$204,264
R43 · FY2023 · AI · contact PI
Chikungunya Recombinant Subunit Vaccine$1,000,000
R44 · FY2021 · AI · contact PI
Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses$876,712
R44 · FY2021 · AI · contact PI
Chikungunya Recombinant Subunit Vaccine$1,000,000
R44 · FY2020 · AI · contact PI
Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses$984,053
R44 · FY2020 · AI · contact PI
Hawaii Biotech COVID-19 Response to PA-18-591$389,739
R44 · FY2020 · AI · contact PI
Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses$839,920
R44 · FY2019 · AI · contact PI
Chikungunya Recombinant Subunit Vaccine$300,000
R43 · FY2017 · AI · contact PI
Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses$956,757
R44 · FY2016 · AI · contact PI
Chikungunya Recombinant Subunit Vaccine$300,000
R43 · FY2016 · AI · contact PI
Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses$1,156,549
R44 · FY2015 · AI · contact PI
Development of a Recombinant Subunit Vaccine for CCHF$268,909
R43 · FY2013 · AI · contact PI
Development of a Recombinant Subunit Vaccine for CCHF$261,990
R43 · FY2012 · AI · contact PI
Recombinant Subunit Vaccine For Tick-Borne Encephalitis$993,477
R44 · FY2011 · AI · contact PI
Development of a MSP1-p42 Subunit Vaccine for Malaria$202,865
R44 · FY2003 · AI
Development of a MSP1-p42 Subunit Vaccine for Malaria$519,457
R44 · FY2002 · AI
Evaluation of Immunogenicity : Malaria Subunit Vaccine$129,871
R43 · FY2002 · AI
Development of a MSP1-p42 Subunit Vaccine for Malaria$537,116
R44 · FY2001 · AI
EXPRESSION OF P FALCIPARUM LSA-1 SUBUNITS$177,172
R43 · FY2001 · AI